Last reviewed · How we verify
: Arnica montana — Competitive Intelligence Brief
marketed
Herbal extract / botanical medicine
Dermatology, Rheumatology, Wound Care
Small molecule
Live · refreshed every 30 min
Target snapshot
: Arnica montana (: Arnica montana) — Abant Izzet Baysal University. Arnica montana is a herbal extract that reduces inflammation and promotes tissue healing through multiple phytochemical constituents including sesquiterpenes and flavonoids.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| : Arnica montana TARGET | : Arnica montana | Abant Izzet Baysal University | marketed | Herbal extract / botanical medicine |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Herbal extract / botanical medicine class)
- Abant Izzet Baysal University · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- : Arnica montana CI watch — RSS
- : Arnica montana CI watch — Atom
- : Arnica montana CI watch — JSON
- : Arnica montana alone — RSS
- Whole Herbal extract / botanical medicine class — RSS
Cite this brief
Drug Landscape (2026). : Arnica montana — Competitive Intelligence Brief. https://druglandscape.com/ci/arnica-montana. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab